Claudia M. Hattinger
Bologna, 40136, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone Metastasis.
Journal: International journal of molecular sciences
Published: September 11, 2025
SMARCAL1 is a new osteosarcoma predisposition gene.
Journal: Journal of the National Cancer Institute
Published: July 08, 2025
SMARCAL1 is a new osteosarcoma predisposition gene.
Journal: Journal of the National Cancer Institute
Published: July 08, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.
Journal: Cells
Published: December 12, 2024
The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets.
Journal: International journal of molecular sciences
Published: October 17, 2024
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Journal: Frontiers in pharmacology
Published: September 15, 2023
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.
Journal: Cancer epidemiology
Published: May 04, 2023
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.
Journal: International journal of molecular sciences
Published: October 29, 2022
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Journal: International journal of molecular sciences
Published: August 12, 2022
Last Updated: 09/26/2026